Natural Skin Care Products as Adjunctive to Prescription Therapy in Moderate to Severe Rosacea
Draelos, Z.D.; Gunt, H.; Levy, S.B..
Journal of Drugs in Dermatology Jdd 18(2): 141-146
2019
ISSN/ISBN: 1545-9616 PMID: 30794364 Document Number: 17716
Background: Rosacea is characterized by irritation associated with erythema, telangiectasias and papules/pustules. Whole formula nature-based sensitive skin products are formulated to maintain skin barrier and appropriate hydration that can lead to soothing benefits.
Document emailed within 1 workday
Related Documents
Jovanovic, Z.; Angabini, N.; Ehlen, S.; Mokos, Z.B.; Subotic, M.; Neufang, G. 2017: Efficacy and Tolerability of a Cosmetic Skin Care Product with Trans-4-t-butylcyclohexanol and Licochalcone a in Subjects with Sensitive Skin Prone to Redness and Rosacea Journal of Drugs in Dermatology: Jdd 16(6): 605-610Moore, A.; Kempers, S.; Murakawa, G.; Weiss, J.; Tauscher, A.; Swinyer, L.; Liu, H.; Leoni, M. 2014: Long-term safety and efficacy of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of a 1-year open-label study Journal of Drugs in Dermatology: Jdd 13(1): 56-61
Fowler, J.; Jackson, M.; Moore, A.; Jarratt, M.; Jones, T.; Meadows, K.; Steinhoff, M.; Rudisill, D.; Leoni, M. 2013: Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies Journal of Drugs in Dermatology: Jdd 12(6): 650-656
Aboutalebi, S.; Strickland, F.M. 2006: Immune protection, natural products, and skin cancer: is there anything new under the sun? Journal of Drugs in Dermatology: Jdd 5(6): 512-517
Isipradit, S. 2008: Efficacy of fluconazole subconjunctival injection as adjunctive therapy for severe recalcitrant fungal corneal ulcer Journal of the Medical Association of Thailand 91(3): 309-315
Vanaman Wilson, M.J.; Jones, I.T.; Bolton, J.; Larsen, L.; Wu, D.C.; Goldman, M.P. 2017: A Randomized, Investigator-Blinded Comparison of two Topical Regimens in Fitzpatrick Skin Types III-Vi with Moderate to Severe Facial Hyperpigmentation Journal of Drugs in Dermatology: Jdd 16(11): 1127-1132
Callender, V.D. 2012: Fitzpatrick skin types and clindamycin phosphate 1.2%/benzoyl peroxide gel: efficacy and tolerability of treatment in moderate to severe acne Journal of Drugs in Dermatology: Jdd 11(5): 643-648
Eichenfield, L.F.; Krakowski, A.C. 2012: Moderate to severe acne in adolescents with skin of color: benefits of a fixed combination clindamycin phosphate 1.2% and benzoyl peroxide 2.5% aqueous gel Journal of Drugs in Dermatology: Jdd 11(7): 818-824
Buetow, S.; Richards, D.; Mitchell, E.A.; Gribben, B.; Adair, V.; Coster, G.; Hight, M. 2005: Teenage use of GP care for moderate to severe asthma in Auckland, New Zealand New Zealand Medical Journal 118(1218): U1558
Jensen, H.; Garsdal, P.; Davies, J. 1990: Amlodipine with enalapril therapy in moderate-severe essential hypertension Journal of Human Hypertension 4(5): 541-545
Gandola, M. 1984: Therapy of severe acne and acne rosacea with oral 13-cis-retinoic acid (Isotretinoin) Acta Vitaminologica et Enzymologica 6(4): 325-337
Del Rosso, J.Q.; Kircik, L.H. 2013: The integration of physiologically-targeted skin care in the management of atopic dermatitis: focus on the use of a cleanser and moisturizer system incorporating a ceramide precursor, filaggrin degradation products, and specific "skin-barrier-friendly" excipients Journal of Drugs in Dermatology: Jdd 12(7): S85-S91
Han, C.; Lofland, J.H.; Zhao, N.; Schenkel, B. 2011: Increased prevalence of psychiatric disorders and health care-associated costs among patients with moderate-to-severe psoriasis Journal of Drugs in Dermatology: Jdd 10(8): 843-850
Mårdh, P-Anders.; Wågström, J.; Landgren, M.; Holmén, J. 2004: Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: 2. Factors that may have influenced the marked changes in sales volumes during the 1990s Infectious Diseases in Obstetrics and Gynecology 12(2): 99-108
Kejriwal, R.; Civil, I. 2009: Time to definitive care for patients with moderate and severe traumatic brain injury--does a trauma system matter? New Zealand Medical Journal 122(1302): 40-46
Goldman, M.P.; Boyce, S.M. 2003: A single-center study of aminolevulinic acid and 417 NM photodynamic therapy in the treatment of moderate to severe acne vulgaris Journal of Drugs in Dermatology: Jdd 2(4): 393-396
Szychta, M.; Wiernicka, A.; Dądalski, M.; Landowski, P.; Klincewicz, B.; Karolewska-Bochenek, K.; Czaja-Bulsa, G.ży.; Jarocka-Cyrta, E.; Korczowski, B.; Sladek, M.; Kierkus, J. 2016: Assessment of induction therapy with infliximab in children with moderate to severe ulcerative colitis: a multi-center study Developmental Period Medicine 20(3): 205-211
Pariser, D.M.; Green, L.J.; Stein Gold, L.; Sugarman, J.L.; Lin, T.; Pillai, R. 2018: Halobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Maintenance of Therapeutic Effect After Cessation of Therapy Journal of Drugs in Dermatology: Jdd 17(7): 723-726
Gottlieb, A.B.; Gordon, K.B.; Lebwohl, M.G.; Caro, I.; Walicke, P.A.; Li, N.; Leonardi, C.L. 2004: Extended efalizumab therapy sustains efficacy without increasing toxicity in patients with moderate to severe chronic plaque psoriasis Journal of Drugs in Dermatology: Jdd 3(6): 614-624
Draelos, Z.D. 2008: The effect of ceramide-containing skin care products on eczema resolution duration Cutis 81(1): 87-91